asa recommendations glp-1 Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement asa glp 1 recommendations GLP-1
Description
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common disease that happens when fat builds up in your liver
Ohio's GLP-1 coverage fractured in 2025-2026 State of Ohio employee plan, OSU Health Plan, and Ohio Medicaid all narrowed weight-loss GLP-1 access
The perioperative management of patients using glucagon-like peptide 1 receptor agonists remains a topic of debate
Developed by Innovent Biologics, it rivals Western treatments like Ozempic while enhancing affordability amid Chinas soaring diabetes burden
